Costs of Cross-listing
There are, however, also disadvantages in deciding to cross-list: increased pressure on executives due to closer public scrutiny; increased reporting and disclosure requirements; additional scrutiny by analysts in advanced market economies, and additional listing fees. Some financial media have argued that the implementation of the Sarbanes-Oxley act in the US has made the NYSE less attractive for cross-listings, but recent academic research finds little evidence to support this, see Doidge, Karolyi, and Stulz (2007).
Read more about this topic: Cross Listing
Famous quotes containing the word costs:
“Like cellulite creams or hair-loss tonics, capital punishment is one of those panaceas that isnt. Only it costs a whole lot more.”
—Anna Quindlen (b. 1952)